Validation of the Persian Version of the National Institute of Health Chronic Prostatitis Symptom Index
5 January 2019
Objectives: To compose a comprehensible and fluent Persian translation of the National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI), and to determine its linguistic validity in a Persian sample population.
Methods: The standard double-back translation method, provided by the previous studies were utilized by three professional linguists to translate the English version of the NIH-CPSI to Persian, and a group of 10 urologists further reviewed and translated questionnaire. The questionnaire was then presented to the sample study, comprised of 60 men with CP/CPPS and 60 controls with adverse urological history, and the collected data was analyzed through IBM-SPSS software to test its validity, evaluative, and discriminatory power, psychometric qualities and internal consistency.
Results: A total of 80 subjects (42 CP/CPPS patients and 38 healthy controls) were considered eligible for this study. The total Persian NIH-CPSI scores and each subdomain showed significant difference (P < 0.001) between the two study groups, indicating a satisfactory discriminant validity for the index. Psychometric analysis established the index to benefit from a high internal consistency. The translation was also considered by both the subjects and the physicians to be easily comprehensible.
Conclusion: The Persian NIH-CPSI is a reliable and valid instrument for evaluating CP/CPPS symptoms in general population, while also benefitting from high discriminatory power, and can be utilized with ease in both clinical practice and laboratory studies.
- asymptomatic inflammatory prostatitis
- asymptomatic inflammatory prostatitides
- chronic prostatitis with chronic pelvic pain syndrome
- national institute of health chronic prostatitis symptom index
Moon TD, Hagen L, Heisey DM. Urinary symptomatology in younger men. Urology. 1997;50:700-3.
Schaeffer AJ. Epidemiology and demographics of prostatitis. Andrologia. 2003;35:252-7.
Krieger JN, Nyberg L, Jr., Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282:236-7.
Turner JA, Ciol MA, Von Korff M, Berger R. Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol. 2003;169:580-3.
Rayegani SM, Razzaghi MR, Raeissadat SA, et al. Extracorporeal Shockwave Therapy Combined with Drug Therapy in Chronic Pelvic Pain Syndrome - A Randomized Clinical Trial. Urol J. 2019.
Litwin MS, McNaughton-Collins M, Fowler FJ, Jr., et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162:369-75.
Litwin MS. A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index. Urology. 2002;60:14-8; discussion 8-9.
Schaeffer AJ, Datta NS, Fowler JE, Jr., et al. Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology. 2002;60:1-4.
Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001;165:842-5.
Schneider H, Brahler E, Ludwig M, et al. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS. Urology. 2004;63:1027-30.
Giubilei G, Mondaini N, Crisci A, et al. The Italian version of the National Institutes of Health Chronic Prostatitis Symptom Index. Eur Urol. 2005;47:805-11.
Collins MM, O'Leary MP, Calhoun EA, et al. The Spanish National Institutes of Health-Chronic Prostatitis Symptom Index: translation and linguistic validation. J Urol. 2001;166:1800-3.
Leskinen MJ, Mehik A, Sarpola A, Tammela TL, Jarvelin MR. The Finnish version of The National Institutes Of Health Chronic Prostatitis Symptom Index correlates well with the visual pain scale: translation and results of a modified linguistic validation study. BJU Int. 2003;92:251-6.
Kunishima Y, Matsukawa M, Takahashi S, et al. National institutes of Health Chronic Prostatitis Symptom Index for Japanese men. Urology. 2002;60:74-7.
Cheah PY, Liong ML, Yuen KH, et al. Reliability and validity of the National Institutes of Health: Chronic Prostatitis Symptom Index in a Malaysian population. World J Urol. 2006;24:79-87.
El-Nashaar A, Fathy A, Zeedan A, Al-Ahwany A, Shamloul R. Validity and reliability of the arabic version of the National Institutes of Health Chronic Prostatitis Symptom Index. Urol Int. 2006;77:227-31.
Korrovits P, Punab M, Mehik A, Mandar R. The Estonian version of the National Institutes of Health chronic prostatitis symptom index. Andrologia. 2006;38:106-9.
Ludwig M, Schroeder-Printzen I, Ludecke G, Weidner W. Comparison of expressed prostatic secretions with urine after prostatic massage--a means to diagnose chronic prostatitis/inflammatory chronic pelvic pain syndrome. Urology. 2000;55:175-7.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.
Nickel JC. Recommendations for the evaluation of patients with prostatitis. World J Urol. 2003;21:75-81.
Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology. 1999;54:229-33.
- Abstract Viewed: 128 times
- Just Accepted/5444 Downloaded: 45 times